Document Detail


The VEGF pathway in cancer and disease: responses, resistance, and the path forward.
MedLine Citation:
PMID:  23209176     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Antiangiogenesis was proposed as a novel target for the treatment of cancer 40 years ago. Since the original hypothesis put forward by Judah Folkman in 1971, factors that mediate angiogenesis, their cellular targets, many of the pathways they signal, and inhibitors of the cytokines and receptors have been identified. Vascular endothelial growth factor (VEGF) is the most prominent among the angiogenic cytokines and is believed to play a central role in the process of neovascularization, both in cancer as well as other inflammatory diseases. This article reviews the biology of VEGF and its receptors, the use of anti-VEGF approaches in clinical disease, the toxicity of these therapies, and the resistance mechanisms that have limited the activity of these agents when used as monotherapy.
Authors:
Mark W Kieran; Raghu Kalluri; Yoon-Jae Cho
Related Documents :
11140866 - A historical perspective on the development of intraoperative lymphatic mapping and sel...
24805056 - Cripto haploinsufficiency affects in vivo colon tumor development.
23024836 - Nuclear accumulation of β-catenin and forkhead box o3a in colon cancer: dangerous liai...
24659636 - The role of depression and neuroimmune axis in the prognosis of cancer patients.
21835826 - A case of colorectal cancer with double-activating epidermal growth factor receptor mut...
9155296 - Testicular cancer: the importance of effective health education.
Publication Detail:
Type:  Journal Article     Date:  2012-12-01
Journal Detail:
Title:  Cold Spring Harbor perspectives in medicine     Volume:  2     ISSN:  2157-1422     ISO Abbreviation:  Cold Spring Harb Perspect Med     Publication Date:  2012  
Date Detail:
Created Date:  2012-12-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101571139     Medline TA:  Cold Spring Harb Perspect Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  -     Citation Subset:  IM    
Affiliation:
Department of Pediatric Medical Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evolutionary rescue: an emerging focus at the intersection between ecology and evolution.
Next Document:  The role of the tumor microenvironment in regulating angiogenesis.